Recommended PRBC to FFP Ratio for Hemorrhagic Resuscitation
For massive hemorrhage resuscitation, use a high-ratio transfusion strategy with at least 1 unit of FFP for every 2 units of PRBC (1:2 FFP:PRBC ratio), with optimal outcomes achieved at ratios approaching 1:1 to 1:1.5. 1, 2
Context-Specific Recommendations
Trauma Patients with Massive Bleeding
The 2023 European trauma guidelines recommend one of two initial strategies: 1
- Fibrinogen concentrate or cryoprecipitate plus PRBC (Grade 1C), OR
- FFP at a minimum ratio of 1:2 FFP:PRBC (Grade 1C)
Additionally, maintain a high platelet:PRBC ratio (Grade 2B) 1
The 2021 ESICM guidelines conditionally recommend high-ratio transfusion strategies (at least 1:2 FFP:PRBC) for critically ill trauma patients with massive bleeding, though they acknowledge the evidence certainty is low. 2
Evidence Supporting Higher Ratios
Mortality outcomes improve progressively as FFP:PRBC ratios increase toward 1:1: 3
- A 1:1 ratio is associated with the lowest mortality (28%) in hemorrhaging trauma patients 3
- Mortality increases incrementally with lower ratios: 1:2 ratio shows odds ratio of 1.23 for mortality, 1:4 ratio shows OR 2.11, and 1:5 ratio shows OR 4.11 3
- Achieving FFP:PRBC ratio ≥1:1.5 within 24 hours significantly improves survival compared to ratios <1:1.5 4
Early administration (within first 6 hours) is critical: 5
- Higher FFP:PRBC ratios in the first 6 hours reduced 6-hour mortality from 37.3% (lowest ratio) to 15.7% (middle ratio) to 2.0% (highest ratio) 5
- In-hospital mortality decreased from 54.9% to 41.1% to 25.5% with progressively higher ratios 5
Hemostasis Benefits
High-ratio transfusion strategies reduce death from exsanguination (RR 0.7,95% CI 0.51-0.96), though overall 24-hour and 30-day mortality differences between 1:1:1 and 1:1:2 ratios in RCTs were not statistically significant due to imprecision. 2
Practical Implementation Algorithm
Initial resuscitation (before coagulation monitoring results):
- Start with 1:1 FFP:PRBC ratio immediately for expected massive hemorrhage 1, 3
- Do not wait to give FFP after 6 units of PRBC - this outdated practice perpetuates coagulopathy 6
- Include platelets early as part of fixed-ratio strategy (1:1:1 or 1:1:2 for FFP:platelets:PRBC) 1
Transition to goal-directed therapy:
- Once coagulation monitoring (preferably viscoelastic testing) is available, switch to targeted therapy based on specific deficits 1
- Consider fibrinogen concentrate or cryoprecipitate if fibrinogen <1.5 g/L 1
Important Caveats
Non-trauma massive bleeding: The evidence for fixed high-ratio strategies in non-traumatic massive hemorrhage (cardiac surgery, postpartum hemorrhage, GI bleeding) is very low certainty, and no formal recommendation can be made. 2 However, the physiologic rationale remains sound.
Survivorship bias concerns: Early observational studies showing mortality benefits may have been confounded by patients who died before plasma could be thawed. 2 However, subgroup analyses excluding very early deaths still showed mortality benefit (RR 0.67). 2
Transfusion-related complications: While higher ratios increase plasma and platelet transfusion volumes, RCT data show no significant increase in ARDS/TRALI, stroke, MI, CHF, infections, or VTE, though confidence intervals are wide. 2
Dose-dependent risks: All blood products carry dose-dependent risks of mortality and infection in cardiac surgery patients, emphasizing the importance of achieving hemostasis quickly to minimize total transfusion burden. 7
Optimal range appears to be 1:1 to 1:1.5 FFP:PRBC based on mortality data, with diminishing returns and potential ceiling effects at higher ratios. 3, 4, 8